Our Pricing

Buy Wegovy Prescription Weight Loss UK

Published on: June 03, 2026

When you buy Wegovy prescription weight loss UK treatment through Cured Pharmacy, you receive genuine semaglutide injections from £79.00, supported by our UK-registered clinical team and superintendent pharmacist Tarun Kumar (GPhC 2233073). Our transparent pricing and three-minute online consultation make accessing this MHRA-licensed treatment straightforward and discreet.

How Wegovy Semaglutide Works for Weight Loss

Wegovy contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics a naturally occurring hormone in your body. This medication works by slowing gastric emptying, reducing appetite signals to the brain, and improving insulin secretion when blood glucose levels are elevated [1]. The result is sustained appetite suppression that helps you consume fewer calories without the constant struggle against hunger.

In the landmark STEP 1 clinical trial, adults using Wegovy alongside lifestyle modifications achieved an average body weight reduction of 14.9% over 68 weeks, compared to 2.4% with placebo [1]. These results represent one of the most significant advances in pharmacological weight management approved by the MHRA for UK patients.

The once-weekly subcutaneous injection offers convenience compared to daily medications, with a gradual dose escalation protocol that minimises gastrointestinal side effects during the initial treatment phase [2]. Your UK prescriber will determine the appropriate starting dose based on your medical history and weight loss goals.

Wegovy Dosing Schedule and Treatment Protocol

Wegovy follows a structured dose escalation schedule designed to improve tolerability whilst achieving therapeutic effect. Treatment typically begins at 0.25mg weekly for four weeks, gradually increasing through 0.5mg, 1mg, and 1.7mg, before reaching the maintenance dose of 2.4mg weekly [2].

This gradual escalation, validated through extensive clinical trials, allows your digestive system to adapt to semaglutide's effects on gastric motility. Patients who rush dosing or skip escalation steps experience significantly higher rates of nausea and gastrointestinal discomfort [2].

What to Expect During Treatment

Most patients notice reduced appetite within the first two weeks of treatment, though maximum weight loss typically occurs between months 3 and 6. Your UK prescriber will monitor your progress through regular check-ins, adjusting your treatment plan if you experience persistent side effects or inadequate response. All patients receiving Wegovy through Cured Pharmacy must engage with lifestyle modifications including dietary changes and increased physical activity, as the medication works synergistically with behavioural interventions to produce optimal outcomes.

Clinical Evidence: STEP Trial Programme Results

The STEP clinical trial programme represents the most comprehensive evaluation of semaglutide for weight management, enrolling over 4,500 adults across multiple international sites. STEP 1, the pivotal trial, demonstrated that 86.4% of participants achieved at least 5% body weight reduction, whilst 69.1% achieved at least 10% reduction, and 50.5% achieved at least 15% reduction [1].

Importantly, weight loss with Wegovy was accompanied by improvements in cardiometabolic risk factors. Participants experienced reductions in waist circumference (average 13.54cm), improvements in systolic blood pressure, and favourable changes in lipid profiles [1]. These secondary benefits contribute to overall cardiovascular health beyond the primary weight loss effect.

Long-term data from the STEP programme shows weight loss is maintained as long as treatment continues, though some weight regain occurs if medication is discontinued [3]. This underscores that Wegovy, like other chronic disease medications, works best as part of ongoing weight management rather than a short-term intervention.

Real-World Effectiveness

Post-marketing surveillance data from UK prescribing patterns confirms that real-world outcomes closely mirror clinical trial results when patients adhere to dosing schedules and lifestyle modifications. Your clinical team at Cured Pharmacy provides ongoing support to maximise treatment adherence and outcomes.

Wegovy Side Effects and Safety Considerations

The most commonly reported side effects with Wegovy are gastrointestinal in nature, including nausea (44% of patients), diarrhoea (30%), vomiting (24%), and constipation (24%) in clinical trials [1]. These effects are typically mild to moderate, occurring most frequently during dose escalation, and often resolve within several weeks as your body adjusts to the medication.

Serious adverse events are uncommon but include potential risks of pancreatitis, gallbladder disease, and hypoglycaemia (particularly in patients taking other glucose-lowering medications). Wegovy carries a boxed warning regarding thyroid C-cell tumours observed in rodent studies, though no causal relationship has been established in humans [2]. Your prescriber will review your personal and family medical history to ensure Wegovy is appropriate for you.

Contraindications include personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, and pregnancy. Women of childbearing potential should use effective contraception during treatment and discontinue Wegovy at least two months before planned conception [2].

Why Choose Cured Pharmacy to Buy Wegovy Online UK

Cured Pharmacy is a fully registered UK pharmacy (GPhC Registration Number 9012511) operating under the clinical oversight of superintendent pharmacist Tarun Kumar (GPhC 2233073). When you buy Wegovy prescription weight loss UK treatment through our platform, you receive genuine MHRA-licensed medication sourced directly from UK-authorised wholesalers, never grey market imports.

Our transparent pricing model shows you the exact cost before you complete your clinical assessment, with no hidden consultation fees or subscription traps. At £79.00, we guarantee competitive UK pricing on Wegovy, and our three-minute online consultation connects you with UK-registered prescribers who assess your suitability based on current NICE and MHRA guidelines.

Every order includes 100% discreet packaging with no external branding, next-day delivery options, and access to our clinical support team for questions throughout your treatment journey. We never share your data with third parties, and all consultations remain confidential between you and your prescriber.

Our Clinical Assessment Process

Your online consultation covers medical history, current medications, weight loss goals, and contraindications. A UK prescriber reviews your submission within hours, and if approved, your medication is dispensed from our GPhC-registered pharmacy and dispatched the same day for eligible orders. Should Wegovy not be appropriate for you, your prescriber will explain why and may suggest alternative treatments better suited to your circumstances.

Wegovy Price UK: Understanding Treatment Costs

The cost of Wegovy varies depending on your prescribed dose and treatment duration. At Cured Pharmacy, Wegovy starts from £79.00 per pen, with transparent pricing displayed before you begin your clinical assessment. This upfront approach ensures you understand the financial commitment before engaging with our prescribers.

Many patients find that the investment in Wegovy produces cost savings in other areas, as reduced appetite naturally decreases food expenditure, and weight loss may reduce costs associated with obesity-related health conditions. Some private medical insurance policies cover GLP-1 medications for weight management when prescribed for clinical obesity, though coverage varies significantly between providers.

Treatment duration is individualised based on your response and weight loss goals. Most patients continue Wegovy for at least 12 months to achieve and consolidate weight loss, with some continuing longer-term as part of chronic weight management. Your prescriber will discuss expected treatment timelines during your consultation.

Scientific References

1. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
2. Novo Nordisk. (2023). Wegovy (semaglutide) injection 2.4 mg: Summary of Product Characteristics. Electronic Medicines Compendium. https://www.medicines.org.uk/emc/product/13799 [accessed 13 August 2026]
3. Rubino, D., et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224 [accessed 13 August 2026]
4. O'Neil, P. M., et al. (2018). Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial. The Lancet, 392(10148), 637–649. https://doi.org/10.1016/S0140-6736(18)31773-2 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.